Want to see AU:PER full AI Analyst Report?
Percheron Therapeutics (PER) Share Forecast & Price Target
13 Followers
PER Analyst Ratings
There are no analyst ratings in the last 3 months.
PER Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | AUD 0.01→AUD 0.01 | hold | 233.33%Upside | Upgraded | 08/21/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | AUD 0.01→AUD 0.01 | hold | 233.33%Upside | Upgraded | 08/21/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | AUD 0.01 | sell | 200.00%Upside | Reiterated | 08/21/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | AUD 0.01 | hold | 233.33%Upside | Reiterated | 08/21/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | AUD 0.01→AUD 0.01 | sell | 200.00%Upside | Downgraded | 08/21/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | AUD 0.01 | hold | 233.33%Upside | Reiterated | 08/21/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldUpgradedAUD 0.01→AUD 0.01 | 08/21/26 | 233.33%Upside | ||
| Google Drug Manufacturers - Specialty and GenericTipRanks - Google | HoldUpgradedAUD 0.01→AUD 0.01 | 08/21/26 | 233.33%Upside | ||
| Anthropic Drug Manufacturers - Specialty and GenericTipRanks - Anthropic | SellReiteratedAUD 0.01 | 08/21/26 | 200.00%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiteratedAUD 0.01 | 08/21/26 | 233.33%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | SellDowngradedAUD 0.01→AUD 0.01 | 08/21/26 | 200.00%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiteratedAUD 0.01 | 08/21/26 | 233.33%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PER Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, PER has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PER average Analyst price target in the past 3 months is ―.
PER Financial Forecast
ConsensusAUD -0.00
PER Earnings Forecast
Next quarter’s earnings estimate for PER is AUD 0.00 with a range of ― to ―. The previous quarter’s EPS was AUD 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusAUD 0.00
PER Sales Forecast
Next quarter’s sales forecast for PER is AUD 0 with a range of ― to ―. The previous quarter’s sales results were AUD 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
PER Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Percheron Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Percheron Therapeutics?
To buy shares of AU:PER, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
